Home LiteratureArticle Details
PMID: 25348155 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Host and viral determinants for MxB restriction of HIV-1 infection.

Retrovirology ·Vol. 11 ·2014-10-25 ·Pages 90

Matreyek KA, Wang W, Serrao E, Singh PK, Levin HL, Engelman A

Abstract

Interferon-induced cellular proteins play important roles in the host response against viral infection. The Mx family of dynamin-like GTPases, which include MxA and MxB, target a wide variety of viruses. Despite considerable evidence demonstrating the breadth of antiviral activity of MxA, human MxB was only recently discovered to specifically inhibit lentiviruses. Here we assess both host and viral determinants that underlie MxB restriction of HIV-1 infection. Heterologous expression of MxB in human osteosarcoma cells potently inhibited HIV-1 infection (~12-fold), yet had little to no effect on divergent retroviruses. The anti-HIV effect manifested as a partial block in the formation of 2-long terminal repeat circle DNA and hence nuclear import, and we accordingly found evidence for an additional post-nuclear entry block. A large number of previously characterized capsid mutations, as well as mutations that abrogated integrase activity, counteracted MxB restriction. MxB expression suppressed integration into gene-enriched regions of chromosomes, similar to affects observed previously when cells were depleted for nuclear transport factors such as transportin 3. MxB activity did not require predicted GTPase active site residues or a series of unstructured loops within the stalk domain that confer functional oligomerization to related dynamin family proteins. In contrast, we observed an N-terminal stretch of residues in MxB to harbor key determinants. Protein localization conferred by a nuclear localization signal (NLS) within the N-terminal 25 residues, which was critical, was fully rescuable by a heterologous NLS. Consistent with this observation, a heterologous nuclear export sequence (NES) abolished full-length MxB activity. We additionally mapped sub-regions within amino acids 26-90 that contribute to MxB activity, finding sequences present within residues 27-50 particularly important. MxB inhibits HIV-1 by interfering with minimally two steps of infection, nuclear entry and post-nuclear trafficking and/or integration, without destabilizing the inherent catalytic activity of viral preintegration complexes. Putative MxB GTPase active site residues and stalk domain Loop 4 -- both previously shown to be necessary for MxA function -- were dispensable for MxB antiviral activity. Instead, we highlight subcellular localization and a yet-determined function(s) present in the unique MxB N-terminal region to be required for HIV-1 restriction.

MeSH Terms
Active Transport, Cell Nucleus Antiviral Agents/metabolism Cell Line HIV-1/immunology,physiology Humans Myxovirus Resistance Proteins/metabolism Virus Integration
Chemicals
Antiviral Agents MX2 protein, human Myxovirus Resistance Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Matreyek Kenneth A
Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, 02215, USA. kmatreyek@gmail.com. | Present address: Department of Genome Sciences, University of Washington, Seattle, WA, 98195, USA. kmatreyek@gmail.com.
Wang Weifeng
Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, 02215, USA. weifeng_wang@dfci.harvard.edu.
Serrao Erik
Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, 02215, USA. erik_serrao@dfci.harvard.edu.
Singh Parmit Kumar
Section on Eukaryotic Transposable Elements, Program in Cellular Regulation and Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA. parmit.singh@nih.gov.
Levin Henry L
Section on Eukaryotic Transposable Elements, Program in Cellular Regulation and Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA. levinh@mail.nih.gov.
Engelman Alan
Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, 02215, USA. alan_engelman@dfci.harvard.edu.
References (64)
64 references, click to expand
  1. The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum.
    J Biol Chem. 2002 Jun 14;277(24):21829-35 PMID: 11916975
  2. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication.
    Virology. 2013 May 25;440(1):8-18 PMID: 23523133
  3. HIV-1 integration in the human genome favors active genes and local hotspots.
    Cell. 2002 Aug 23;110(4):521-9 PMID: 12202041
  4. Visualization of the intracellular behavior of HIV in living cells.
    J Cell Biol. 2002 Nov 11;159(3):441-52 PMID: 12417576
  5. Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.
    J Virol. 2003 Jan;77(2):1469-80 PMID: 12502862
  6. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus.
    J Virol. 2003 Sep;77(18):10119-24 PMID: 12941923
  7. Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages.
    J Virol. 2004 Jan;78(2):658-68 PMID: 14694097
  8. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Nature. 2004 Feb 26;427(6977):848-53 PMID: 14985764
  9. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.
    J Virol. 2004 Jun;78(11):5670-8 PMID: 15140964
  10. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB.
    Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8957-62 PMID: 15184662
  11. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.
    Nature. 2004 Jul 29;430(6999):569-73 PMID: 15243629
  12. Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements.
    Proc Natl Acad Sci U S A. 1981 Jan;78(1):124-8 PMID: 6264426
  13. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
    J Virol. 1991 Aug;65(8):3973-85 PMID: 1830110
  14. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
    J Virol. 1995 Jan;69(1):376-86 PMID: 7983732
  15. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
    J Virol. 1995 May;69(5):2729-36 PMID: 7535863
  16. Analysis of human immunodeficiency virus type 1 integrase mutants.
    Virology. 1995 Aug 1;211(1):332-5 PMID: 7544046
  17. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope.
    J Biol Chem. 1996 Sep 20;271(38):23478-86 PMID: 8798556
  18. Nuclear cotransport mechanism of cytoplasmic human MxB protein.
    J Biol Chem. 1997 Dec 19;272(51):32353-9 PMID: 9405443
  19. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
    Gene Ther. 1999 May;6(5):715-28 PMID: 10505094
  20. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase.
    J Biol Chem. 2004 Dec 3;279(49):51545-53 PMID: 15452123
  21. Dnm1 forms spirals that are structurally tailored to fit mitochondria.
    J Cell Biol. 2005 Sep 26;170(7):1021-7 PMID: 16186251
  22. Retroviral DNA integration: viral and cellular determinants of target-site selection.
    PLoS Pathog. 2006 Jun;2(6):e60 PMID: 16789841
  23. Mammalian RNA polymerase II core promoters: insights from genome-wide studies.
    Nat Rev Genet. 2007 Jun;8(6):424-36 PMID: 17486122
  24. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Nature. 2008 Jan 24;451(7177):425-30 PMID: 18200009
  25. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
    Cell Host Microbe. 2008 Apr 17;3(4):245-52 PMID: 18342597
  26. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
    J Virol. 2008 Dec;82(23):11682-94 PMID: 18799573
  27. The SET complex acts as a barrier to autointegration of HIV-1.
    PLoS Pathog. 2009 Mar;5(3):e1000327 PMID: 19266025
  28. Quantitative analysis of HIV-1 preintegration complexes.
    Methods. 2009 Apr;47(4):283-90 PMID: 19233280
  29. Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration.
    Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3135-40 PMID: 20133638
  30. BEDTools: a flexible suite of utilities for comparing genomic features.
    Bioinformatics. 2010 Mar 15;26(6):841-2 PMID: 20110278
  31. Structural basis of oligomerization in the stalk region of dynamin-like MxA.
    Nature. 2010 May 27;465(7297):502-6 PMID: 20428112
  32. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.
    PLoS Pathog. 2011 Mar;7(3):e1001313 PMID: 21423673
  33. A diverse range of gene products are effectors of the type I interferon antiviral response.
    Nature. 2011 Apr 28;472(7344):481-5 PMID: 21478870
  34. An evolutionary perspective on the broad antiviral specificity of MxA.
    Curr Opin Microbiol. 2013 Aug;16(4):493-9 PMID: 23725670
  35. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity.
    PLoS Pathog. 2013;9(10):e1003693 PMID: 24130490
  36. The interferon-inducible MxB protein inhibits HIV-1 infection.
    Cell Host Microbe. 2013 Oct 16;14(4):398-410 PMID: 24055605
  37. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
    Nature. 2013 Oct 24;502(7472):559-62 PMID: 24048477
  38. MX2 is an interferon-induced inhibitor of HIV-1 infection.
    Nature. 2013 Oct 24;502(7472):563-6 PMID: 24121441
  39. Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle.
    Retrovirology. 2013;10:87 PMID: 23938039
  40. Mx proteins: antiviral gatekeepers that restrain the uninvited.
    Microbiol Mol Biol Rev. 2013 Dec;77(4):551-66 PMID: 24296571
  41. Host and viral determinants of Mx2 antiretroviral activity.
    J Virol. 2014 Jul;88(14):7738-52 PMID: 24760893
  42. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
    J Virol. 2014 Aug;88(16):9017-26 PMID: 24899177
  43. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
    Retrovirology. 2014;11:68 PMID: 25123063
  44. Structural insight into HIV-1 restriction by MxB.
    Cell Host Microbe. 2014 Nov 12;16(5):627-38 PMID: 25312384
  45. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.
    J Virol. 2001 Apr;75(8):3626-35 PMID: 11264352
  46. A quantitative assay for HIV DNA integration in vivo.
    Nat Med. 2001 May;7(5):631-4 PMID: 11329067
  47. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.
    EMBO J. 2001 Jun 15;20(12):3272-81 PMID: 11406603
  48. BLAT--the BLAST-like alignment tool.
    Genome Res. 2002 Apr;12(4):656-64 PMID: 11932250
  49. The human genome browser at UCSC.
    Genome Res. 2002 Jun;12(6):996-1006 PMID: 12045153
  50. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
    Nature. 2011 Jun 30;474(7353):654-7 PMID: 21613998
  51. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.
    Nature. 2011 Jun 30;474(7353):658-61 PMID: 21720370
  52. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.
    J Virol. 2011 Aug;85(15):7818-27 PMID: 21593146
  53. Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.
    J Biol Chem. 2011 Aug 12;286(32):27959-70 PMID: 21680743
  54. Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop.
    J Biol Chem. 2011 Oct 28;286(43):37858-65 PMID: 21900240
  55. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function.
    Immunity. 2011 Oct 28;35(4):514-25 PMID: 21962493
  56. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.
    PLoS Pathog. 2011 Dec;7(12):e1002439 PMID: 22174692
  57. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
    J Virol. 2012 Apr;86(7):3861-79 PMID: 22278243
  58. HIV DNA integration.
    Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006890 PMID: 22762018
  59. Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.
    Cell Host Microbe. 2012 Oct 18;12(4):598-604 PMID: 23084925
  60. Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.
    J Virol. 2013 Jan;87(1):648-58 PMID: 23097450
  61. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor.
    Nucleic Acids Res. 2012 Dec;40(22):11518-30 PMID: 23042676
  62. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm.
    Retrovirology. 2013;10:20 PMID: 23414560
  63. Single-cell imaging of HIV-1 provirus (SCIP).
    Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5636-41 PMID: 23513220
  64. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Nature. 2002 Aug 8;418(6898):646-50 PMID: 12167863
Article Info
Journal
Retrovirology
Abbr.
Retrovirology
ISSN
1742-4690
Published
2014-10-25
Epub
2014-00-25
Pages
90
Language
English
Region
England
NLM ID
101216893
PMCID
PMC4213484
Subset
IM
Grants
NIAID NIH HHS · T32 AI007245 · United States
Intramural NIH HHS · United States
NIAID NIH HHS · AI052014 · United States
NIAID NIH HHS · AI060354 · United States
NIAID NIH HHS · R01 AI052014 · United States
NIAID NIH HHS · P30 AI060354 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com